Validity and Reliability of CTQ-SSS in Carpal Tunnel Syndrome.

Last updated: April 20, 2023
Sponsor: Ahram Canadian University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Carpal Tunnel Syndrome

Treatment

Shorter Version of the CTQ-SSS

Clinical Study ID

NCT05838976
012/00X0021
  • Ages 18-60
  • All Genders

Study Summary

To determine the validity and reliability of the shorter version of the CTQ-SSS in patients with carpal tunnel syndrome (CTS) undergoing nonsurgical management.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients diagnosed with carpal tunnel syndrome based on clinical presentation and/ornerve conduction studies.
  • Patients aged 18 years to 60 years old.
  • Patients who are undergoing nonsurgical management for carpal tunnel syndrome.

Exclusion

Exclusion Criteria:

  • Patients with a history of hand or wrist surgery within the past 6 months.
  • Patients with severe hand or wrist pain that would prevent completion of the outcomemeasures or interfere with their ability to participate in the study.
  • Patients with severe cognitive impairment or language barrier that would preventunderstanding of the study instructions or interfere with their ability to participatein the study.
  • Patients with any other medical condition that could affect hand function or interferewith test completion.

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Shorter Version of the CTQ-SSS
Phase:
Study Start date:
May 01, 2023
Estimated Completion Date:
October 31, 2023

Connect with a study center

  • Outpatient clinic of faculty of physical therapy, Ahram Canadian University

    Al Ḩayy Ath Thāmin, Giza 3221405
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.